activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147189	CHEMBL927933	Activity of human ALK4 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	115.0	CHEMBL5310	Homo sapiens	Activity	%	115.0
	2147189	CHEMBL927933	Activity of human ALK4 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	115.0	CHEMBL5310	Homo sapiens	Activity	%	115.0
	2470097	CHEMBL1032239	Inhibition of ACVR1B at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5310	Homo sapiens	INH	%	10.0
Not Evaluated	2476596	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2476799	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2478638	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2478841	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2479696	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5310	Homo sapiens	Activity		
	2480695	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	2.0	CHEMBL5310	Homo sapiens	Activity	%	2.0
	2512037	CHEMBL970558	Inhibition of ALK4 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	11.0	CHEMBL5310	Homo sapiens	INH	%	11.0
Not Evaluated	2577317	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2577520	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2593522	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL5310	Homo sapiens	Activity		
	2593725	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	3.5	CHEMBL5310	Homo sapiens	Activity	%	3.5
	2593991	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	3.1	CHEMBL5310	Homo sapiens	Activity	%	3.1
Not Evaluated	2594934	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2595137	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2595203	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2596334	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL5310	Homo sapiens	Activity		
Not Evaluated	2597603	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5310	Homo sapiens	Activity		
	2597806	CHEMBL993460	Binding affinity to human ALK4 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Activity	%	5.45	CHEMBL5310	Homo sapiens	Activity	%	5.45
	2721548	CHEMBL1060956	Inhibition of ALK4 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	2724672	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	69.4	CHEMBL5310	Homo sapiens	INH	%	69.4
	2724673	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	N#Cc1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccc3F)n2)cc1		CHEMBL552429	=	Inhibition	%	36.6	CHEMBL5310	Homo sapiens	INH	%	36.6
	2724674	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCCO3)n1		CHEMBL562347	=	Inhibition	%	49.3	CHEMBL5310	Homo sapiens	INH	%	49.3
	2724675	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc(F)cc2)n1		CHEMBL551283	=	Inhibition	%	34.5	CHEMBL5310	Homo sapiens	INH	%	34.5
	2724676	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL551623	=	Inhibition	%	29.8	CHEMBL5310	Homo sapiens	INH	%	29.8
	2724677	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL560207	=	Inhibition	%	76.9	CHEMBL5310	Homo sapiens	INH	%	76.9
	2724678	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccn3)n2)cc1		CHEMBL558665	=	Inhibition	%	73.7	CHEMBL5310	Homo sapiens	INH	%	73.7
	2724679	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc(O)c(O)c3)n(-c3ccccc3O)n2)cc1		CHEMBL551021	=	Inhibition	%	93.7	CHEMBL5310	Homo sapiens	INH	%	93.7
	2724680	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccccc3F)n(-c3ccc4c(c3)OCO4)n2)cc1		CHEMBL560287	=	Inhibition	%	41.9	CHEMBL5310	Homo sapiens	INH	%	41.9
	2724681	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	COc1ccc(-c2cc(-c3ccc(C(N)=O)cc3)nn2-c2ccccc2F)cc1OC		CHEMBL559618	=	Inhibition	%	70.4	CHEMBL5310	Homo sapiens	INH	%	70.4
	2724682	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-n2nc(-c3ccc(C(N)=O)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL560347	=	Inhibition	%	66.8	CHEMBL5310	Homo sapiens	INH	%	66.8
	2724683	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	Cc1cccc(-n2nc(-c3ccc(C#N)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL549312	=	Inhibition	%	77.7	CHEMBL5310	Homo sapiens	INH	%	77.7
	2724684	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3F)n2)cc1		CHEMBL560346	=	Inhibition	%	50.7	CHEMBL5310	Homo sapiens	INH	%	50.7
	2724685	CHEMBL1062751	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccn3)n2)cc1		CHEMBL565038	=	Inhibition	%	74.7	CHEMBL5310	Homo sapiens	INH	%	74.7
	2724686	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	25.7	CHEMBL5310	Homo sapiens	INH	%	25.7
	2724687	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	N#Cc1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccc3F)n2)cc1		CHEMBL552429	=	Inhibition	%	13.3	CHEMBL5310	Homo sapiens	INH	%	13.3
	2724688	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCCO3)n1		CHEMBL562347	=	Inhibition	%	28.5	CHEMBL5310	Homo sapiens	INH	%	28.5
	2724689	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc(F)cc2)n1		CHEMBL551283	=	Inhibition	%	25.0	CHEMBL5310	Homo sapiens	INH	%	25.0
	2724690	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C(N)=O)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL551623	=	Inhibition	%	15.6	CHEMBL5310	Homo sapiens	INH	%	15.6
	2724691	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-c2nc(-c3ccc(C#N)cc3)cn2-c2ccc3c(c2)OCO3)n1		CHEMBL560207	=	Inhibition	%	45.5	CHEMBL5310	Homo sapiens	INH	%	45.5
	2724692	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cn(-c3ccc4c(c3)OCO4)c(-c3ccccn3)n2)cc1		CHEMBL558665	=	Inhibition	%	65.6	CHEMBL5310	Homo sapiens	INH	%	65.6
	2724693	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc(O)c(O)c3)n(-c3ccccc3O)n2)cc1		CHEMBL551021	=	Inhibition	%	73.8	CHEMBL5310	Homo sapiens	INH	%	73.8
	2724694	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccccc3F)n(-c3ccc4c(c3)OCO4)n2)cc1		CHEMBL560287	=	Inhibition	%	3.2	CHEMBL5310	Homo sapiens	INH	%	3.2
	2724695	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	COc1ccc(-c2cc(-c3ccc(C(N)=O)cc3)nn2-c2ccccc2F)cc1OC		CHEMBL559618	=	Inhibition	%	32.1	CHEMBL5310	Homo sapiens	INH	%	32.1
	2724696	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-n2nc(-c3ccc(C(N)=O)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL560347	=	Inhibition	%	39.4	CHEMBL5310	Homo sapiens	INH	%	39.4
	2724697	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	Cc1cccc(-n2nc(-c3ccc(C#N)cc3)cc2-c2ccc3c(c2)OCO3)n1		CHEMBL549312	=	Inhibition	%	53.6	CHEMBL5310	Homo sapiens	INH	%	53.6
	2724698	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccc3F)n2)cc1		CHEMBL560346	=	Inhibition	%	15.5	CHEMBL5310	Homo sapiens	INH	%	15.5
	2724699	CHEMBL1062750	Inhibition of ALK4 expressed in baculovirus/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs	B	NC(=O)c1ccc(-c2cc(-c3ccc4c(c3)OCO4)n(-c3ccccn3)n2)cc1		CHEMBL565038	=	Inhibition	%	70.0	CHEMBL5310	Homo sapiens	INH	%	70.0
	2896494	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896495	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896496	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896497	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896498	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896499	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896500	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896501	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896502	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896503	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896504	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896505	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	330.0	CHEMBL5310	Homo sapiens	Kd	nM	330.0
	2896506	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896507	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896508	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896509	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896510	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896511	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896512	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896513	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896514	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896515	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896516	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896517	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896518	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896519	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896520	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896521	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896522	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	950.0	CHEMBL5310	Homo sapiens	Kd	nM	950.0
	2896523	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	3000.0	CHEMBL5310	Homo sapiens	Kd	nM	3000.0
	2896524	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Kd	nM	190.0	CHEMBL5310	Homo sapiens	Kd	nM	190.0
	2896525	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896526	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	680.0	CHEMBL5310	Homo sapiens	Kd	nM	680.0
	2896527	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896528	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896529	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896530	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2896531	CHEMBL1051278	Binding constant for ACVR1B kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	2992196	CHEMBL1044499	Inhibition of human ALK4 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	72.0	CHEMBL5310	Homo sapiens	INH	%	72.0
	3052521	CHEMBL1047772	Residual activity of ACVR1B at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	89.0	CHEMBL5310	Homo sapiens	Residual activity	%	89.0
	3052773	CHEMBL1046506	Residual activity of ACVR1B at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	109.0	CHEMBL5310	Homo sapiens	Residual activity	%	109.0
	3054082	CHEMBL1066600	Residual activity of ACVR1B at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	102.0	CHEMBL5310	Homo sapiens	Residual activity	%	102.0
	3055369	CHEMBL1047772	Residual activity of ACVR1B at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	85.0	CHEMBL5310	Homo sapiens	Residual activity	%	85.0
	3055621	CHEMBL1046506	Residual activity of ACVR1B at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	93.0	CHEMBL5310	Homo sapiens	Residual activity	%	93.0
	3056926	CHEMBL1066600	Residual activity of ACVR1B at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	100.0	CHEMBL5310	Homo sapiens	Residual activity	%	100.0
	3058246	CHEMBL1047772	Residual activity of ACVR1B at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	96.0	CHEMBL5310	Homo sapiens	Residual activity	%	96.0
	3058498	CHEMBL1046506	Residual activity of ACVR1B at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	104.0	CHEMBL5310	Homo sapiens	Residual activity	%	104.0
	3062436	CHEMBL1048629	Binding affinity to human ACVR1B at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	95.0	CHEMBL5310	Homo sapiens	Activity	%	95.0
	3063571	CHEMBL1045157	Binding affinity to human ACVR1B at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	87.0	CHEMBL5310	Homo sapiens	Activity	%	87.0
	3063661	CHEMBL1038872	Binding affinity to human ACVR1B at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	3065842	CHEMBL1068648	Inhibition of ACVR1B at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL5310	Homo sapiens	INH	%	0.0
	3066908	CHEMBL1068648	Inhibition of ACVR1B at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	2.0	CHEMBL5310	Homo sapiens	INH	%	2.0
	3072844	CHEMBL1066600	Residual activity of ACVR1B at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	97.0	CHEMBL5310	Homo sapiens	Residual activity	%	97.0
	3081441	CHEMBL1070640	Inhibition of ALK4 at 10 uM	B	CCc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL594371	=	Inhibition	%	76.0	CHEMBL5310	Homo sapiens	INH	%	76.0
	3224752	CHEMBL1102591	Inhibition of ALK4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3224999	CHEMBL1102591	Inhibition of ALK4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3331816	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3333231	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3334636	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3336056	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3337442	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3337690	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3339021	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3339277	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3340584	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3342000	CHEMBL1168583	Inhibition of ACVR1B at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3358443	CHEMBL1174057	Inhibition of ACVR1B at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	85.0	CHEMBL5310	Homo sapiens	INH	%	85.0
	3358885	CHEMBL1174057	Inhibition of ACVR1B at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	63.0	CHEMBL5310	Homo sapiens	INH	%	63.0
	3443333	CHEMBL1243985	Inhibition of ALK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	88.0	CHEMBL5310	Homo sapiens	INH	%	88.0
	3443550	CHEMBL1243985	Inhibition of ALK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	91.0	CHEMBL5310	Homo sapiens	INH	%	91.0
	3444705	CHEMBL1243985	Inhibition of ALK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	99.0	CHEMBL5310	Homo sapiens	INH	%	99.0
	3445019	CHEMBL1244713	Binding affinity to ACVR1B	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	86.0	CHEMBL5310	Homo sapiens	Kd	nM	86.0
	3445329	CHEMBL1243985	Inhibition of ALK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	3445546	CHEMBL1243985	Inhibition of ALK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	18.0	CHEMBL5310	Homo sapiens	INH	%	18.0
	3445764	CHEMBL1243985	Inhibition of ALK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	75.0	CHEMBL5310	Homo sapiens	INH	%	75.0
	3445954	CHEMBL1243985	Inhibition of ALK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	52.0	CHEMBL5310	Homo sapiens	INH	%	52.0
	3448686	CHEMBL1244713	Binding affinity to ACVR1B	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	3449549	CHEMBL1244713	Binding affinity to ACVR1B	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	3449974	CHEMBL1244713	Binding affinity to ACVR1B	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	3450282	CHEMBL1244713	Binding affinity to ACVR1B	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	3450903	CHEMBL1244713	Binding affinity to ACVR1B	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	3451193	CHEMBL1244713	Binding affinity to ACVR1B	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	uM	10.0
	3463166	CHEMBL1251626	Inhibition of ACVR1B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	0.0	CHEMBL5310	Homo sapiens	INH	%	0.0
	3463385	CHEMBL1251626	Inhibition of ACVR1B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	-2.0	CHEMBL5310	Homo sapiens	INH	%	-2.0
	3463929	CHEMBL1251626	Inhibition of ACVR1B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	7.0	CHEMBL5310	Homo sapiens	INH	%	7.0
	5121116	CHEMBL1648171	Inhibition of human ALK4 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	112.0	CHEMBL5310	Homo sapiens	INH	%	112.0
	5242943	CHEMBL1685637	Inhibition of ALK4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	87.0	CHEMBL5310	Homo sapiens	INH	%	87.0
	5243782	CHEMBL1685886	Inhibition of ALK4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	103.0	CHEMBL5310	Homo sapiens	INH	%	103.0
	5243895	CHEMBL1685637	Inhibition of ALK4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	124.0	CHEMBL5310	Homo sapiens	INH	%	124.0
	5244003	CHEMBL1685886	Inhibition of ALK4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	114.0	CHEMBL5310	Homo sapiens	INH	%	114.0
	5244876	CHEMBL1685637	Inhibition of ALK4 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	106.0	CHEMBL5310	Homo sapiens	INH	%	106.0
	5244984	CHEMBL1685886	Inhibition of ALK4 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	111.0	CHEMBL5310	Homo sapiens	INH	%	111.0
	5245135	CHEMBL1685637	Inhibition of ALK4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	115.0	CHEMBL5310	Homo sapiens	INH	%	115.0
	5245965	CHEMBL1685886	Inhibition of ALK4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	114.0	CHEMBL5310	Homo sapiens	INH	%	114.0
	6340962	CHEMBL1827286	Activity of ACVR1B kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	95.0	CHEMBL5310	Homo sapiens	Activity	%	95.0
	6366233	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	CN1CCN(c2ccc(-c3cc(-c4c[nH]nc4-c4ccccn4)ccn3)cn2)CC1		CHEMBL1829512	=	Inhibition	%	31.0	CHEMBL5310	Homo sapiens	INH	%	31.0
	6366257	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205736	=	Inhibition	%	59.0	CHEMBL5310	Homo sapiens	INH	%	59.0
	6366258	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)nc1		CHEMBL1829513	=	Inhibition	%	58.0	CHEMBL5310	Homo sapiens	INH	%	58.0
	6366259	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cccnc3)c2)nc1		CHEMBL1829514	=	Inhibition	%	62.0	CHEMBL5310	Homo sapiens	INH	%	62.0
Not Active	6366260	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cnc4ccccc4c3)c2)nc1		CHEMBL1829515		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366261	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cccc4cccnc34)c2)nc1		CHEMBL1829516		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366262	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cncnc3)c2)nc1		CHEMBL1829602		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	6366263	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	Cn1cc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1828640	=	Inhibition	%	1.0	CHEMBL5310	Homo sapiens	INH	%	1.0
	6366264	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cccn3)c2)nc1		CHEMBL1829504	=	Inhibition	%	37.0	CHEMBL5310	Homo sapiens	INH	%	37.0
	6366265	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3ccnc3)c2)nc1		CHEMBL1829505	=	Inhibition	%	62.0	CHEMBL5310	Homo sapiens	INH	%	62.0
	6366266	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cnc4ccccc43)c2)nc1		CHEMBL1829506	=	Inhibition	%	62.0	CHEMBL5310	Homo sapiens	INH	%	62.0
Not Active	6366267	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(N3CCCCC3)c2)nc1		CHEMBL1829507		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366268	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	CN1CCN(c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)CC1		CHEMBL1829508		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366269	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccncc2)nc1		CHEMBL1829509		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	6366270	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	Inhibition	%	42.0	CHEMBL5310	Homo sapiens	INH	%	42.0
Not Active	6366271	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	COc1cccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)c1		CHEMBL382799		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	6366272	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	CN(C)CCCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1829511	=	Inhibition	%	38.0	CHEMBL5310	Homo sapiens	INH	%	38.0
Not Active	6366273	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL205736		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366274	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)nc1		CHEMBL1829513		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366275	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cccnc3)c2)nc1		CHEMBL1829514		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366276	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cnc4ccccc4c3)c2)nc1		CHEMBL1829515		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366277	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cccc4cccnc34)c2)nc1		CHEMBL1829516		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366278	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3cncnc3)c2)nc1		CHEMBL1829602		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	6366279	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	Cn1cc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1828640	=	Inhibition	%	83.0	CHEMBL5310	Homo sapiens	INH	%	83.0
Not Active	6366280	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cccn3)c2)nc1		CHEMBL1829504		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366281	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3ccnc3)c2)nc1		CHEMBL1829505		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366282	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cnc4ccccc43)c2)nc1		CHEMBL1829506		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366283	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc(N3CCCCC3)c2)nc1		CHEMBL1829507		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366284	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	CN1CCN(c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)CC1		CHEMBL1829508		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Not Active	6366285	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	c1ccc(-c2n[nH]cc2-c2ccncc2)nc1		CHEMBL1829509		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	6366286	CHEMBL1831612	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 100 nM after 16 hrs by luciferase reporter gene assay relative to control	B	CN(C)CCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL424676	=	Inhibition	%	4.0	CHEMBL5310	Homo sapiens	INH	%	4.0
	6366287	CHEMBL1831611	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX at 1 uM after 16 hrs by luciferase reporter gene assay relative to control	B	COc1ccccc1-c1cc(-c2c[nH]nc2-c2ccccn2)ccn1		CHEMBL1829510	=	Inhibition	%	71.0	CHEMBL5310	Homo sapiens	INH	%	71.0
	6366295	CHEMBL1831614	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	Cn1cc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1828640	=	IC50	nM	224.0	CHEMBL5310	Homo sapiens	IC50	nM	224.0
	6366296	CHEMBL1831614	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3cccn3)c2)nc1		CHEMBL1829504	=	IC50	nM	882.0	CHEMBL5310	Homo sapiens	IC50	nM	882.0
	6366297	CHEMBL1831614	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	c1ccc(-c2n[nH]cc2-c2ccnc(-n3ccnc3)c2)nc1		CHEMBL1829505	=	IC50	nM	956.0	CHEMBL5310	Homo sapiens	IC50	nM	956.0
	6366298	CHEMBL1831614	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	CN(C)CCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL424676	=	IC50	nM	46.0	CHEMBL5310	Homo sapiens	IC50	nM	46.0
	6366299	CHEMBL1831614	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	>	IC50	nM	1000.0	CHEMBL5310	Homo sapiens	IC50	nM	1000.0
	6366300	CHEMBL1831614	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	CN(C)CCCOc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cn1		CHEMBL1829511	=	IC50	nM	18.0	CHEMBL5310	Homo sapiens	IC50	nM	18.0
	6366301	CHEMBL1831614	Inhibition of Activin A in human HEK293 cells transfected with luciferase and FAST-2 gene expression vector A3-LUX after 16 hrs by luciferase reporter gene assay	B	CN1CCN(c2ccc(-c3cc(-c4c[nH]nc4-c4ccccn4)ccn3)cn2)CC1		CHEMBL1829512	=	IC50	nM	108.0	CHEMBL5310	Homo sapiens	IC50	nM	108.0
	7567341	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	1500.0	CHEMBL5310	Homo sapiens	Kd	nM	1500.0
	7567800	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7568297	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	96.0	CHEMBL5310	Homo sapiens	Kd	nM	96.0
	7568729	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7569314	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7569804	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7570267	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7570694	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7571290	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7571305	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	860.0	CHEMBL5310	Homo sapiens	Kd	nM	860.0
	7571781	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7572244	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7572660	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	97.0	CHEMBL5310	Homo sapiens	Kd	nM	97.0
	7573286	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	330.0	CHEMBL5310	Homo sapiens	Kd	nM	330.0
	7573762	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	10.0	CHEMBL5310	Homo sapiens	Kd	nM	10.0
	7574231	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7574639	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7574807	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	4900.0	CHEMBL5310	Homo sapiens	Kd	nM	4900.0
	7575268	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7575739	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7576204	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7576612	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	6700.0	CHEMBL5310	Homo sapiens	Kd	nM	6700.0
	7576781	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7577240	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7577718	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7578188	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	58.0	CHEMBL5310	Homo sapiens	Kd	nM	58.0
	7578593	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7578789	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7579163	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7579613	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7580087	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7581147	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7581532	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7581977	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	=	Kd	nM	2400.0	CHEMBL5310	Homo sapiens	Kd	nM	2400.0
	7582470	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7582870	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7583493	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7583890	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7584335	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7584364	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7584826	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1100.0	CHEMBL5310	Homo sapiens	Kd	nM	1100.0
	7585230	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7585823	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7586231	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7586706	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7587160	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7587784	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7588214	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7588685	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7589136	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	3000.0	CHEMBL5310	Homo sapiens	Kd	nM	3000.0
	7589731	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	86.0	CHEMBL5310	Homo sapiens	Kd	nM	86.0
	7590198	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7590672	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7591123	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7591280	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7591702	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7592174	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7592647	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7593100	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7593247	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7593682	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7594154	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7594627	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7595215	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7595659	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7596133	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7596604	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7596609	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7597187	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7597640	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7598113	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5310	Homo sapiens	Kd	nM	10000.0
	7598583	CHEMBL1908640	Binding constant for ACVR1B kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	680.0	CHEMBL5310	Homo sapiens	Kd	nM	680.0
	7959671	CHEMBL1932326	Inhibition of ALK4	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	35000.0	CHEMBL5310	Homo sapiens	IC50	uM	35.0
	7959672	CHEMBL1932326	Inhibition of ALK4	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	44000.0	CHEMBL5310	Homo sapiens	IC50	uM	44.0
	7992171	CHEMBL1935985	Inhibition of ALK4 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	27.0	CHEMBL5310	Homo sapiens	INH	%	27.0
	10849698	CHEMBL2019657	Inhibition of ALK4	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL5310	Homo sapiens	IC50	uM	40.0
	10868657	CHEMBL2026331	Inhibition of ALK4	B	Cc1cccc(-n2nccc2-c2ccc3ncn(C)c(=O)c3c2)n1		CHEMBL2024684	=	IC50	nM	59.0	CHEMBL5310	Homo sapiens	IC50	nM	59.0
	10980231	CHEMBL2065104	Inhibition of ALK4 at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL5310	Homo sapiens	INH	%	25.0
	10980232	CHEMBL2065104	Inhibition of ALK4 at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL5310	Homo sapiens	INH	%	15.0
	10980291	CHEMBL2065135	Inhibition of ALK4 by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL5310	Homo sapiens	IC50	uM	10.0
Active	10990925	CHEMBL2071850	Binding affinity to human Alk4	B	CCNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070615		Activity			CHEMBL5310	Homo sapiens	Activity		
	12046235	CHEMBL2157255	Inhibition of ACVR1B at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-0.8	CHEMBL5310	Homo sapiens	INH	%	-0.8
	12163056	CHEMBL2182420	Inhibition of Alk4 at 2.5 uM	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Inhibition	%	99.0	CHEMBL5310	Homo sapiens	INH	%	99.0
	12173749	CHEMBL2212087	Inhibition of ACVR1B assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	43.0	CHEMBL5310	Homo sapiens	Activity	%	43.0
	12185165	CHEMBL2216365	Inhibition of ACVR1B	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5310	Homo sapiens	pIC50		5.0
	12226952	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	114.0	CHEMBL5310	Homo sapiens	Residual Activity	%	114.0
	12226953	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	114.0	CHEMBL5310	Homo sapiens	Residual Activity	%	114.0
	12226954	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	126.0	CHEMBL5310	Homo sapiens	Residual Activity	%	126.0
	12226955	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	121.0	CHEMBL5310	Homo sapiens	Residual Activity	%	121.0
	12226956	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	121.0	CHEMBL5310	Homo sapiens	Residual Activity	%	121.0
	12226957	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	123.0	CHEMBL5310	Homo sapiens	Residual Activity	%	123.0
	12226958	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	118.0	CHEMBL5310	Homo sapiens	Residual Activity	%	118.0
	12226959	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12226960	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	123.0	CHEMBL5310	Homo sapiens	Residual Activity	%	123.0
	12226961	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	123.0	CHEMBL5310	Homo sapiens	Residual Activity	%	123.0
	12226962	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	137.0	CHEMBL5310	Homo sapiens	Residual Activity	%	137.0
	12226963	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	123.0	CHEMBL5310	Homo sapiens	Residual Activity	%	123.0
	12226964	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	125.0	CHEMBL5310	Homo sapiens	Residual Activity	%	125.0
	12226965	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	129.0	CHEMBL5310	Homo sapiens	Residual Activity	%	129.0
	12226966	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	136.0	CHEMBL5310	Homo sapiens	Residual Activity	%	136.0
	12226967	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	120.0	CHEMBL5310	Homo sapiens	Residual Activity	%	120.0
	12226968	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	122.0	CHEMBL5310	Homo sapiens	Residual Activity	%	122.0
	12226969	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	132.0	CHEMBL5310	Homo sapiens	Residual Activity	%	132.0
	12226970	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	131.0	CHEMBL5310	Homo sapiens	Residual Activity	%	131.0
	12226971	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	110.0	CHEMBL5310	Homo sapiens	Residual Activity	%	110.0
	12226972	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	132.0	CHEMBL5310	Homo sapiens	Residual Activity	%	132.0
	12226973	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	129.0	CHEMBL5310	Homo sapiens	Residual Activity	%	129.0
	12226974	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	133.0	CHEMBL5310	Homo sapiens	Residual Activity	%	133.0
	12226975	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	130.0	CHEMBL5310	Homo sapiens	Residual Activity	%	130.0
	12226976	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12226977	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	125.0	CHEMBL5310	Homo sapiens	Residual Activity	%	125.0
	12226978	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12226979	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12226980	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12226981	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	107.0	CHEMBL5310	Homo sapiens	Residual Activity	%	107.0
	12226982	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	-3.0	CHEMBL5310	Homo sapiens	Residual Activity	%	-3.0
	12226983	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12226984	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	117.0	CHEMBL5310	Homo sapiens	Residual Activity	%	117.0
	12226985	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	120.0	CHEMBL5310	Homo sapiens	Residual Activity	%	120.0
	12226986	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	120.0	CHEMBL5310	Homo sapiens	Residual Activity	%	120.0
	12226987	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	115.0	CHEMBL5310	Homo sapiens	Residual Activity	%	115.0
	12226988	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	117.0	CHEMBL5310	Homo sapiens	Residual Activity	%	117.0
	12226989	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	115.0	CHEMBL5310	Homo sapiens	Residual Activity	%	115.0
	12226990	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	1.0	CHEMBL5310	Homo sapiens	Residual Activity	%	1.0
	12226991	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	112.0	CHEMBL5310	Homo sapiens	Residual Activity	%	112.0
	12226992	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	136.0	CHEMBL5310	Homo sapiens	Residual Activity	%	136.0
	12226993	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	129.0	CHEMBL5310	Homo sapiens	Residual Activity	%	129.0
	12226994	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	108.0	CHEMBL5310	Homo sapiens	Residual Activity	%	108.0
	12226995	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	64.0	CHEMBL5310	Homo sapiens	Residual Activity	%	64.0
	12226996	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	126.0	CHEMBL5310	Homo sapiens	Residual Activity	%	126.0
	12226997	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	127.0	CHEMBL5310	Homo sapiens	Residual Activity	%	127.0
	12226998	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	126.0	CHEMBL5310	Homo sapiens	Residual Activity	%	126.0
	12226999	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	112.0	CHEMBL5310	Homo sapiens	Residual Activity	%	112.0
	12227000	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	148.0	CHEMBL5310	Homo sapiens	Residual Activity	%	148.0
	12227001	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	148.0	CHEMBL5310	Homo sapiens	Residual Activity	%	148.0
	12227002	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	127.0	CHEMBL5310	Homo sapiens	Residual Activity	%	127.0
	12227003	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	125.0	CHEMBL5310	Homo sapiens	Residual Activity	%	125.0
	12227004	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	85.0	CHEMBL5310	Homo sapiens	Residual Activity	%	85.0
	12227005	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	137.0	CHEMBL5310	Homo sapiens	Residual Activity	%	137.0
	12227006	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	139.0	CHEMBL5310	Homo sapiens	Residual Activity	%	139.0
	12227007	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	126.0	CHEMBL5310	Homo sapiens	Residual Activity	%	126.0
	12227008	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	124.0	CHEMBL5310	Homo sapiens	Residual Activity	%	124.0
	12227009	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	149.0	CHEMBL5310	Homo sapiens	Residual Activity	%	149.0
	12227010	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	134.0	CHEMBL5310	Homo sapiens	Residual Activity	%	134.0
	12227011	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	124.0	CHEMBL5310	Homo sapiens	Residual Activity	%	124.0
	12227012	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	102.0	CHEMBL5310	Homo sapiens	Residual Activity	%	102.0
	12227013	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	128.0	CHEMBL5310	Homo sapiens	Residual Activity	%	128.0
	12227014	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	122.0	CHEMBL5310	Homo sapiens	Residual Activity	%	122.0
	12227015	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	123.0	CHEMBL5310	Homo sapiens	Residual Activity	%	123.0
	12227016	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	119.0	CHEMBL5310	Homo sapiens	Residual Activity	%	119.0
	12227017	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	127.0	CHEMBL5310	Homo sapiens	Residual Activity	%	127.0
	12227018	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	112.0	CHEMBL5310	Homo sapiens	Residual Activity	%	112.0
	12227019	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	122.0	CHEMBL5310	Homo sapiens	Residual Activity	%	122.0
	12227020	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	115.0	CHEMBL5310	Homo sapiens	Residual Activity	%	115.0
	12227021	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	121.0	CHEMBL5310	Homo sapiens	Residual Activity	%	121.0
	12227022	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	117.0	CHEMBL5310	Homo sapiens	Residual Activity	%	117.0
	12227023	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12227024	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	119.0	CHEMBL5310	Homo sapiens	Residual Activity	%	119.0
	12227025	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	135.0	CHEMBL5310	Homo sapiens	Residual Activity	%	135.0
	12227026	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	131.0	CHEMBL5310	Homo sapiens	Residual Activity	%	131.0
	12227027	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	131.0	CHEMBL5310	Homo sapiens	Residual Activity	%	131.0
	12227028	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	127.0	CHEMBL5310	Homo sapiens	Residual Activity	%	127.0
	12227029	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	126.0	CHEMBL5310	Homo sapiens	Residual Activity	%	126.0
	12227030	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	130.0	CHEMBL5310	Homo sapiens	Residual Activity	%	130.0
	12227031	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	70.0	CHEMBL5310	Homo sapiens	Residual Activity	%	70.0
	12227032	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	108.0	CHEMBL5310	Homo sapiens	Residual Activity	%	108.0
	12227033	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	100.0	CHEMBL5310	Homo sapiens	Residual Activity	%	100.0
	12227034	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12227035	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	82.0	CHEMBL5310	Homo sapiens	Residual Activity	%	82.0
	12227036	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12227037	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12227038	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	115.0	CHEMBL5310	Homo sapiens	Residual Activity	%	115.0
	12227039	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	87.0	CHEMBL5310	Homo sapiens	Residual Activity	%	87.0
	12227040	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	88.0	CHEMBL5310	Homo sapiens	Residual Activity	%	88.0
	12227041	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12227042	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL5310	Homo sapiens	Residual Activity	%	90.0
	12227043	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12227044	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	96.0	CHEMBL5310	Homo sapiens	Residual Activity	%	96.0
	12227045	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12227046	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	86.0	CHEMBL5310	Homo sapiens	Residual Activity	%	86.0
	12227047	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12227048	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	94.0	CHEMBL5310	Homo sapiens	Residual Activity	%	94.0
	12229577	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	103.0	CHEMBL5310	Homo sapiens	Residual Activity	%	103.0
	12229578	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229579	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	110.0	CHEMBL5310	Homo sapiens	Residual Activity	%	110.0
	12229580	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229581	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	24.0	CHEMBL5310	Homo sapiens	Residual Activity	%	24.0
	12229582	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12229583	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	90.0	CHEMBL5310	Homo sapiens	Residual Activity	%	90.0
	12229584	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229585	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229586	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	122.0	CHEMBL5310	Homo sapiens	Residual Activity	%	122.0
	12229587	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	110.0	CHEMBL5310	Homo sapiens	Residual Activity	%	110.0
	12229588	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	118.0	CHEMBL5310	Homo sapiens	Residual Activity	%	118.0
	12229589	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229590	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	38.0	CHEMBL5310	Homo sapiens	Residual Activity	%	38.0
	12229591	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	119.0	CHEMBL5310	Homo sapiens	Residual Activity	%	119.0
	12229592	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	67.0	CHEMBL5310	Homo sapiens	Residual Activity	%	67.0
	12229593	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229594	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12229595	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	107.0	CHEMBL5310	Homo sapiens	Residual Activity	%	107.0
	12229596	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	112.0	CHEMBL5310	Homo sapiens	Residual Activity	%	112.0
	12229597	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	96.0	CHEMBL5310	Homo sapiens	Residual Activity	%	96.0
	12229598	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	101.0	CHEMBL5310	Homo sapiens	Residual Activity	%	101.0
	12229599	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	100.0	CHEMBL5310	Homo sapiens	Residual Activity	%	100.0
	12229600	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	88.0	CHEMBL5310	Homo sapiens	Residual Activity	%	88.0
	12229601	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	123.0	CHEMBL5310	Homo sapiens	Residual Activity	%	123.0
	12229602	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	103.0	CHEMBL5310	Homo sapiens	Residual Activity	%	103.0
	12229603	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	98.0	CHEMBL5310	Homo sapiens	Residual Activity	%	98.0
	12229604	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	92.0	CHEMBL5310	Homo sapiens	Residual Activity	%	92.0
	12229605	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	88.0	CHEMBL5310	Homo sapiens	Residual Activity	%	88.0
	12229606	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	115.0	CHEMBL5310	Homo sapiens	Residual Activity	%	115.0
	12229607	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12229608	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	81.0	CHEMBL5310	Homo sapiens	Residual Activity	%	81.0
	12229609	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	7.0	CHEMBL5310	Homo sapiens	Residual Activity	%	7.0
	12229610	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229611	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	84.0	CHEMBL5310	Homo sapiens	Residual Activity	%	84.0
	12229612	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	86.0	CHEMBL5310	Homo sapiens	Residual Activity	%	86.0
	12229613	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	101.0	CHEMBL5310	Homo sapiens	Residual Activity	%	101.0
	12229614	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	72.0	CHEMBL5310	Homo sapiens	Residual Activity	%	72.0
	12229615	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	122.0	CHEMBL5310	Homo sapiens	Residual Activity	%	122.0
	12229616	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	116.0	CHEMBL5310	Homo sapiens	Residual Activity	%	116.0
	12229617	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	115.0	CHEMBL5310	Homo sapiens	Residual Activity	%	115.0
	12229618	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	109.0	CHEMBL5310	Homo sapiens	Residual Activity	%	109.0
	12229619	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12229620	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	108.0	CHEMBL5310	Homo sapiens	Residual Activity	%	108.0
	12229621	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	101.0	CHEMBL5310	Homo sapiens	Residual Activity	%	101.0
	12229622	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	110.0	CHEMBL5310	Homo sapiens	Residual Activity	%	110.0
	12229623	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	72.0	CHEMBL5310	Homo sapiens	Residual Activity	%	72.0
	12229624	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	31.0	CHEMBL5310	Homo sapiens	Residual Activity	%	31.0
	12229625	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	113.0	CHEMBL5310	Homo sapiens	Residual Activity	%	113.0
	12229626	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	100.0	CHEMBL5310	Homo sapiens	Residual Activity	%	100.0
	12229627	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229628	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	114.0	CHEMBL5310	Homo sapiens	Residual Activity	%	114.0
	12229629	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	94.0	CHEMBL5310	Homo sapiens	Residual Activity	%	94.0
	12229630	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	114.0	CHEMBL5310	Homo sapiens	Residual Activity	%	114.0
	12229631	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	125.0	CHEMBL5310	Homo sapiens	Residual Activity	%	125.0
	12229632	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229633	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	83.0	CHEMBL5310	Homo sapiens	Residual Activity	%	83.0
	12229634	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	87.0	CHEMBL5310	Homo sapiens	Residual Activity	%	87.0
	12229635	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	102.0	CHEMBL5310	Homo sapiens	Residual Activity	%	102.0
	12229636	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	57.0	CHEMBL5310	Homo sapiens	Residual Activity	%	57.0
	12229637	CHEMBL2219375	Millipore: Percentage of residual kinase activity of ACVR1B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	107.0	CHEMBL5310	Homo sapiens	Residual Activity	%	107.0
	12229638	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	48.0	CHEMBL5310	Homo sapiens	Residual Activity	%	48.0
	12229639	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	75.0	CHEMBL5310	Homo sapiens	Residual Activity	%	75.0
	12229640	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	124.0	CHEMBL5310	Homo sapiens	Residual Activity	%	124.0
	12229641	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12229642	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	116.0	CHEMBL5310	Homo sapiens	Residual Activity	%	116.0
	12229643	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	120.0	CHEMBL5310	Homo sapiens	Residual Activity	%	120.0
	12229644	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12229645	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	101.0	CHEMBL5310	Homo sapiens	Residual Activity	%	101.0
	12229646	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	88.0	CHEMBL5310	Homo sapiens	Residual Activity	%	88.0
	12229647	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	82.0	CHEMBL5310	Homo sapiens	Residual Activity	%	82.0
	12229648	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	99.0	CHEMBL5310	Homo sapiens	Residual Activity	%	99.0
	12229649	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	94.0	CHEMBL5310	Homo sapiens	Residual Activity	%	94.0
	12229650	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229651	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	60.0	CHEMBL5310	Homo sapiens	Residual Activity	%	60.0
	12229652	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229653	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	83.0	CHEMBL5310	Homo sapiens	Residual Activity	%	83.0
	12229654	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	87.0	CHEMBL5310	Homo sapiens	Residual Activity	%	87.0
	12229655	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL5310	Homo sapiens	Residual Activity	%	94.0
	12229656	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	83.0	CHEMBL5310	Homo sapiens	Residual Activity	%	83.0
	12229657	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	74.0	CHEMBL5310	Homo sapiens	Residual Activity	%	74.0
	12229658	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	98.0	CHEMBL5310	Homo sapiens	Residual Activity	%	98.0
	12229659	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	88.0	CHEMBL5310	Homo sapiens	Residual Activity	%	88.0
	12229660	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	93.0	CHEMBL5310	Homo sapiens	Residual Activity	%	93.0
	12229661	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	72.0	CHEMBL5310	Homo sapiens	Residual Activity	%	72.0
	12229662	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229663	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	91.0	CHEMBL5310	Homo sapiens	Residual Activity	%	91.0
	12229664	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	87.0	CHEMBL5310	Homo sapiens	Residual Activity	%	87.0
	12229665	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	85.0	CHEMBL5310	Homo sapiens	Residual Activity	%	85.0
	12229666	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229667	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	103.0	CHEMBL5310	Homo sapiens	Residual Activity	%	103.0
	12229668	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	-4.0	CHEMBL5310	Homo sapiens	Residual Activity	%	-4.0
	12229669	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	57.0	CHEMBL5310	Homo sapiens	Residual Activity	%	57.0
	12229670	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	101.0	CHEMBL5310	Homo sapiens	Residual Activity	%	101.0
	12229671	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	104.0	CHEMBL5310	Homo sapiens	Residual Activity	%	104.0
	12229672	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	119.0	CHEMBL5310	Homo sapiens	Residual Activity	%	119.0
	12229673	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	103.0	CHEMBL5310	Homo sapiens	Residual Activity	%	103.0
	12229674	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	91.0	CHEMBL5310	Homo sapiens	Residual Activity	%	91.0
	12229675	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	110.0	CHEMBL5310	Homo sapiens	Residual Activity	%	110.0
	12229676	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	-6.0	CHEMBL5310	Homo sapiens	Residual Activity	%	-6.0
	12229677	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	101.0	CHEMBL5310	Homo sapiens	Residual Activity	%	101.0
	12229678	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	100.0	CHEMBL5310	Homo sapiens	Residual Activity	%	100.0
	12229679	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229680	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	64.0	CHEMBL5310	Homo sapiens	Residual Activity	%	64.0
	12229681	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	5.0	CHEMBL5310	Homo sapiens	Residual Activity	%	5.0
	12229682	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	96.0	CHEMBL5310	Homo sapiens	Residual Activity	%	96.0
	12229683	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	110.0	CHEMBL5310	Homo sapiens	Residual Activity	%	110.0
	12229684	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229685	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	100.0	CHEMBL5310	Homo sapiens	Residual Activity	%	100.0
	12229686	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	91.0	CHEMBL5310	Homo sapiens	Residual Activity	%	91.0
	12229687	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	92.0	CHEMBL5310	Homo sapiens	Residual Activity	%	92.0
	12229688	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	47.0	CHEMBL5310	Homo sapiens	Residual Activity	%	47.0
	12229689	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	84.0	CHEMBL5310	Homo sapiens	Residual Activity	%	84.0
	12229690	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	13.0	CHEMBL5310	Homo sapiens	Residual Activity	%	13.0
	12229691	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	86.0	CHEMBL5310	Homo sapiens	Residual Activity	%	86.0
	12229692	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229693	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	88.0	CHEMBL5310	Homo sapiens	Residual Activity	%	88.0
	12229694	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229695	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12229696	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	99.0	CHEMBL5310	Homo sapiens	Residual Activity	%	99.0
	12229697	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12229698	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	25.0	CHEMBL5310	Homo sapiens	Residual Activity	%	25.0
	12229699	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	102.0	CHEMBL5310	Homo sapiens	Residual Activity	%	102.0
	12229700	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	108.0	CHEMBL5310	Homo sapiens	Residual Activity	%	108.0
	12229701	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	94.0	CHEMBL5310	Homo sapiens	Residual Activity	%	94.0
	12229702	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229703	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229704	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	112.0	CHEMBL5310	Homo sapiens	Residual Activity	%	112.0
	12229705	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	117.0	CHEMBL5310	Homo sapiens	Residual Activity	%	117.0
	12229706	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	93.0	CHEMBL5310	Homo sapiens	Residual Activity	%	93.0
	12229707	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	112.0	CHEMBL5310	Homo sapiens	Residual Activity	%	112.0
	12229708	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	120.0	CHEMBL5310	Homo sapiens	Residual Activity	%	120.0
	12229709	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	69.0	CHEMBL5310	Homo sapiens	Residual Activity	%	69.0
	12229710	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	76.0	CHEMBL5310	Homo sapiens	Residual Activity	%	76.0
	12229711	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	119.0	CHEMBL5310	Homo sapiens	Residual Activity	%	119.0
	12229712	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	115.0	CHEMBL5310	Homo sapiens	Residual Activity	%	115.0
	12229713	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	72.0	CHEMBL5310	Homo sapiens	Residual Activity	%	72.0
	12229714	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	102.0	CHEMBL5310	Homo sapiens	Residual Activity	%	102.0
	12229715	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	99.0	CHEMBL5310	Homo sapiens	Residual Activity	%	99.0
	12229716	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	114.0	CHEMBL5310	Homo sapiens	Residual Activity	%	114.0
	12229717	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	11.0	CHEMBL5310	Homo sapiens	Residual Activity	%	11.0
	12229718	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	86.0	CHEMBL5310	Homo sapiens	Residual Activity	%	86.0
	12229719	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	47.0	CHEMBL5310	Homo sapiens	Residual Activity	%	47.0
	12229720	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	99.0	CHEMBL5310	Homo sapiens	Residual Activity	%	99.0
	12229721	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	63.0	CHEMBL5310	Homo sapiens	Residual Activity	%	63.0
	12229722	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	56.0	CHEMBL5310	Homo sapiens	Residual Activity	%	56.0
	12229723	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	94.0	CHEMBL5310	Homo sapiens	Residual Activity	%	94.0
	12229724	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229725	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	23.0	CHEMBL5310	Homo sapiens	Residual Activity	%	23.0
	12229726	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229727	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	72.0	CHEMBL5310	Homo sapiens	Residual Activity	%	72.0
	12229728	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	117.0	CHEMBL5310	Homo sapiens	Residual Activity	%	117.0
	12229729	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	86.0	CHEMBL5310	Homo sapiens	Residual Activity	%	86.0
	12229730	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	76.0	CHEMBL5310	Homo sapiens	Residual Activity	%	76.0
	12229731	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	113.0	CHEMBL5310	Homo sapiens	Residual Activity	%	113.0
	12229732	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	22.0	CHEMBL5310	Homo sapiens	Residual Activity	%	22.0
	12229733	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	101.0	CHEMBL5310	Homo sapiens	Residual Activity	%	101.0
	12229734	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	103.0	CHEMBL5310	Homo sapiens	Residual Activity	%	103.0
	12229735	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229736	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	113.0	CHEMBL5310	Homo sapiens	Residual Activity	%	113.0
	12229737	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	115.0	CHEMBL5310	Homo sapiens	Residual Activity	%	115.0
	12229738	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229739	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL5310	Homo sapiens	Residual Activity	%	0.0
	12229740	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL5310	Homo sapiens	Residual Activity	%	108.0
	12229741	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	93.0	CHEMBL5310	Homo sapiens	Residual Activity	%	93.0
	12229742	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	47.0	CHEMBL5310	Homo sapiens	Residual Activity	%	47.0
	12229743	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12229744	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229745	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	114.0	CHEMBL5310	Homo sapiens	Residual Activity	%	114.0
	12229746	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	112.0	CHEMBL5310	Homo sapiens	Residual Activity	%	112.0
	12229747	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	72.0	CHEMBL5310	Homo sapiens	Residual Activity	%	72.0
	12229748	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	35.0	CHEMBL5310	Homo sapiens	Residual Activity	%	35.0
	12229749	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	88.0	CHEMBL5310	Homo sapiens	Residual Activity	%	88.0
	12229750	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	23.0	CHEMBL5310	Homo sapiens	Residual Activity	%	23.0
	12229751	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	95.0	CHEMBL5310	Homo sapiens	Residual Activity	%	95.0
	12229752	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229753	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	110.0	CHEMBL5310	Homo sapiens	Residual Activity	%	110.0
	12229754	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	68.0	CHEMBL5310	Homo sapiens	Residual Activity	%	68.0
	12229755	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	102.0	CHEMBL5310	Homo sapiens	Residual Activity	%	102.0
	12229756	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	40.0	CHEMBL5310	Homo sapiens	Residual Activity	%	40.0
	12229757	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	29.0	CHEMBL5310	Homo sapiens	Residual Activity	%	29.0
	12229758	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	34.0	CHEMBL5310	Homo sapiens	Residual Activity	%	34.0
	12229759	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229760	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	120.0	CHEMBL5310	Homo sapiens	Residual Activity	%	120.0
	12229761	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	105.0	CHEMBL5310	Homo sapiens	Residual Activity	%	105.0
	12229762	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	66.0	CHEMBL5310	Homo sapiens	Residual Activity	%	66.0
	12229763	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	83.0	CHEMBL5310	Homo sapiens	Residual Activity	%	83.0
	12229764	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12229765	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	110.0	CHEMBL5310	Homo sapiens	Residual Activity	%	110.0
	12229766	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	39.0	CHEMBL5310	Homo sapiens	Residual Activity	%	39.0
	12229767	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-4.0	CHEMBL5310	Homo sapiens	Residual Activity	%	-4.0
	12229768	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	118.0	CHEMBL5310	Homo sapiens	Residual Activity	%	118.0
	12229769	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	109.0	CHEMBL5310	Homo sapiens	Residual Activity	%	109.0
	12229770	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	84.0	CHEMBL5310	Homo sapiens	Residual Activity	%	84.0
	12229771	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	121.0	CHEMBL5310	Homo sapiens	Residual Activity	%	121.0
	12229772	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	36.0	CHEMBL5310	Homo sapiens	Residual Activity	%	36.0
	12229773	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	117.0	CHEMBL5310	Homo sapiens	Residual Activity	%	117.0
	12229774	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	113.0	CHEMBL5310	Homo sapiens	Residual Activity	%	113.0
	12229775	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	80.0	CHEMBL5310	Homo sapiens	Residual Activity	%	80.0
	12229776	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	96.0	CHEMBL5310	Homo sapiens	Residual Activity	%	96.0
	12229777	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	109.0	CHEMBL5310	Homo sapiens	Residual Activity	%	109.0
	12229778	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	111.0	CHEMBL5310	Homo sapiens	Residual Activity	%	111.0
	12229779	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	107.0	CHEMBL5310	Homo sapiens	Residual Activity	%	107.0
	12229780	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	108.0	CHEMBL5310	Homo sapiens	Residual Activity	%	108.0
	12229781	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	24.0	CHEMBL5310	Homo sapiens	Residual Activity	%	24.0
	12229782	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	0.0	CHEMBL5310	Homo sapiens	Residual Activity	%	0.0
	12229783	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	107.0	CHEMBL5310	Homo sapiens	Residual Activity	%	107.0
	12229784	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	119.0	CHEMBL5310	Homo sapiens	Residual Activity	%	119.0
	12229785	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	106.0	CHEMBL5310	Homo sapiens	Residual Activity	%	106.0
	12229786	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	77.0	CHEMBL5310	Homo sapiens	Residual Activity	%	77.0
	12229787	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	97.0	CHEMBL5310	Homo sapiens	Residual Activity	%	97.0
	12229788	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	82.0	CHEMBL5310	Homo sapiens	Residual Activity	%	82.0
	12229789	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	85.0	CHEMBL5310	Homo sapiens	Residual Activity	%	85.0
	12229790	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	100.0	CHEMBL5310	Homo sapiens	Residual Activity	%	100.0
	12229791	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	112.0	CHEMBL5310	Homo sapiens	Residual Activity	%	112.0
	12229792	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	93.0	CHEMBL5310	Homo sapiens	Residual Activity	%	93.0
	12229793	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL5310	Homo sapiens	Residual Activity	%	103.0
	12229794	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	8.0	CHEMBL5310	Homo sapiens	Residual Activity	%	8.0
	12229795	CHEMBL2219376	Millipore: Percentage of residual kinase activity of ACVR1B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	92.0	CHEMBL5310	Homo sapiens	Residual Activity	%	92.0
	12700116	CHEMBL2344128	Inhibition of recombinant ACVR1B (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	1.0	CHEMBL5310	Homo sapiens	INH	%	1.0
	12728905	CHEMBL2350237	Inhibition of ALK4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	112.0	CHEMBL5310	Homo sapiens	Activity	%	112.0
	12730047	CHEMBL2352071	Inhibition of ALK4 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	93.0	CHEMBL5310	Homo sapiens	Activity	%	93.0
	12730937	CHEMBL2350110	Inhibition of ALK4 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	94.0	CHEMBL5310	Homo sapiens	Activity	%	94.0
	12731184	CHEMBL2350237	Inhibition of ALK4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL5310	Homo sapiens	Activity	%	94.0
Not Active	13321766	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cccc5ncccc45)cnn3c2)cc1		CHEMBL502351		IC50			CHEMBL5310	Homo sapiens	IC50		
Not Active	13321767	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)cc1		CHEMBL2385600		IC50			CHEMBL5310	Homo sapiens	IC50		
	13321799	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	25740.0	CHEMBL5310	Homo sapiens	IC50	nM	25740.0
	13321805	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	CC(C)Oc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL2385597	=	IC50	nM	9622.0	CHEMBL5310	Homo sapiens	IC50	nM	9622.0
	13321808	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	c1cc(N2CCOCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385579	=	IC50	nM	5930.0	CHEMBL5310	Homo sapiens	IC50	nM	5930.0
	13321812	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	c1cc(-c2cnn3cc(-c4ccc(N5CCNCC5)cc4)cnc23)c2cccnc2c1		CHEMBL2385591	=	IC50	nM	4090.0	CHEMBL5310	Homo sapiens	IC50	nM	4090.0
	13321816	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	c1cc(N2CCNCC2)ccc1-c1cnc2c(-c3cn[nH]c3)cnn2c1		CHEMBL2385586	=	IC50	nM	3420.0	CHEMBL5310	Homo sapiens	IC50	nM	3420.0
	13321823	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	COc1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1		CHEMBL511563	=	IC50	nM	1840.0	CHEMBL5310	Homo sapiens	IC50	nM	1840.0
	13321824	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	1825.0	CHEMBL5310	Homo sapiens	IC50	nM	1825.0
	13321837	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCOCC6)cc5)cnc34)ccnc2c1		CHEMBL2385582	=	IC50	nM	326.0	CHEMBL5310	Homo sapiens	IC50	nM	326.0
	13321844	CHEMBL2390523	Inhibition of ALK4 (unknown origin)	B	CN1CCN(c2ccc(-c3cnc4c(-c5ccnc6ccccc56)cnn4c3)cc2)CC1		CHEMBL2385596	=	IC50	nM	183.0	CHEMBL5310	Homo sapiens	IC50	nM	183.0
	13375953	CHEMBL2406113	Inhibition of ACVR1B (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-4.0	CHEMBL5310	Homo sapiens	INH	%	-4.0
	13439907	CHEMBL2428336	Competitive binding affinity to ACVR1B (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	13445413	CHEMBL2428336	Competitive binding affinity to ACVR1B (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	13448472	CHEMBL2428336	Competitive binding affinity to ACVR1B (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	13451727	CHEMBL2428336	Competitive binding affinity to ACVR1B (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	13872209	CHEMBL3102396	Inhibition of human ALK4 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	106.0	CHEMBL5310	Homo sapiens	Activity	%	106.0
	13953293	CHEMBL3130922	Inhibition of human ALK4 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	96.0	CHEMBL5310	Homo sapiens	Activity	%	96.0
	13953368	CHEMBL3130922	Inhibition of human ALK4 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	85.0	CHEMBL5310	Homo sapiens	Activity	%	85.0
	13954711	CHEMBL3130922	Inhibition of human ALK4 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	85.0	CHEMBL5310	Homo sapiens	Activity	%	85.0
	14582434	CHEMBL3240217	Inhibition of human ALK4 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	109.0	CHEMBL5310	Homo sapiens	Activity	%	109.0
	14659685	CHEMBL3269163	Inhibition of ALK4 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	13.0	CHEMBL5310	Homo sapiens	IC50	uM	0.013
	14659686	CHEMBL3269163	Inhibition of ALK4 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	70.0	CHEMBL5310	Homo sapiens	IC50	uM	0.07
	14659687	CHEMBL3269163	Inhibition of ALK4 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	23.0	CHEMBL5310	Homo sapiens	IC50	uM	0.023
	14659688	CHEMBL3269163	Inhibition of ALK4 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	199.0	CHEMBL5310	Homo sapiens	IC50	uM	0.199
	14659689	CHEMBL3269163	Inhibition of ALK4 (unknown origin) by radioisotopic assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9118.0	CHEMBL5310	Homo sapiens	IC50	uM	9.118
	14659696	CHEMBL3269169	Inhibition of ALK4 (unknown origin) assessed as residual activity at 0.01 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	39.0	CHEMBL5310	Homo sapiens	Activity	%	39.0
	14659697	CHEMBL3269170	Inhibition of ALK4 (unknown origin) assessed as residual activity at 0.1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	7.0	CHEMBL5310	Homo sapiens	Activity	%	7.0
	14659698	CHEMBL3269171	Inhibition of ALK4 (unknown origin) assessed as residual activity at 1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	6.0	CHEMBL5310	Homo sapiens	Activity	%	6.0
	14659699	CHEMBL3269172	Inhibition of ALK4 (unknown origin) assessed as residual activity at 10 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	1.0	CHEMBL5310	Homo sapiens	Activity	%	1.0
	15014098	CHEMBL3361853	Inhibition of ACVR1B (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	-2.5	CHEMBL5310	Homo sapiens	INH	%	-2.5
	15754276	CHEMBL3631702	Inhibition of ACVR1B (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	7.1	CHEMBL5310	Homo sapiens	INH	%	7.1
	15755849	CHEMBL3630039	Inhibition of ACVR1B (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	82.0	CHEMBL5310	Homo sapiens	Activity	%	82.0
	15756112	CHEMBL3631722	Inhibition of ALK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	42.36	CHEMBL5310	Homo sapiens	INH	%	42.36
	15757707	CHEMBL3631722	Inhibition of ALK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Outside typical range	CHEMBL166031	=	Inhibition	%	-13.93	CHEMBL5310	Homo sapiens	INH	%	-13.93
	15757987	CHEMBL3631722	Inhibition of ALK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-11.44	CHEMBL5310	Homo sapiens	INH	%	-11.44
	16425252	CHEMBL3751271	Inhibition of ACVR1B (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-3.9	CHEMBL5310	Homo sapiens	INH	%	-3.9
	16450754	CHEMBL3762140	Inhibition of ACVR1B (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	70.7	CHEMBL5310	Homo sapiens	INH	%	70.7
	16485695	CHEMBL3773976	Inhibition of human recombinant ACVR1B assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	16495332	CHEMBL3776645	Inhibition of N-terminal His6-tagged recombinant human ALK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-7.0	CHEMBL5310	Homo sapiens	Activity	%	-7.0
	16508101	CHEMBL3776645	Inhibition of N-terminal His6-tagged recombinant human ALK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	33.0	CHEMBL5310	Homo sapiens	Activity	%	33.0
	16509078	CHEMBL3776645	Inhibition of N-terminal His6-tagged recombinant human ALK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	21.0	CHEMBL5310	Homo sapiens	Activity	%	21.0
Not Active	16514072	CHEMBL3782142	Inhibition of partial length human ACVR1B expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	16597034	CHEMBL3812220	Inhibition of human ACVR1B (187 to 505 amino acid residues) expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	90.0	CHEMBL5310	Homo sapiens	Activity	%	90.0
	16613767	CHEMBL3816560	Inhibition of human ALK4 at 1 uM using casein as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-3.0	CHEMBL5310	Homo sapiens	INH	%	-3.0
	16618285	CHEMBL3817000	Inhibition of recombinant human GST-tagged ACVR1B (150 to 505 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	16628463	CHEMBL3820166	Inhibition of human recombinant GST-tagged ALK4 expressed in baculovirus by FRET assay	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	=	IC50	nM	31.0	CHEMBL5310	Homo sapiens	IC50	nM	31.0
	16837425	CHEMBL3876096	Inhibition of human recombinant GST-tagged ALK4 catalytic domain (150 to 505 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL5310	Homo sapiens	IC50	nM	10000.0
Active	17880867	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	601.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	601.0
Inactive	17880868	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880869	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880870	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880871	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17880872	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	767.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	767.0
Inactive	17880873	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880874	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880875	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880876	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880877	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880878	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880879	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880880	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880881	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880882	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880883	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880884	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880885	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880886	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880887	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880888	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880889	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880890	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880891	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880892	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880893	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880894	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880895	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880896	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880897	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880898	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880899	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880900	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880901	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880902	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880903	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880904	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880905	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880906	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880907	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880908	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880909	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880910	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17880911	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	811.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	811.0
Active	17880912	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	142.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	142.0
Inactive	17880913	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880914	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880915	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880916	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880917	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880918	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880919	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880920	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880921	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880922	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880923	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880924	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880925	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880926	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880927	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880928	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17880929	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Kd	nM	16.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	16.0
Inactive	17880930	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880931	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880932	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880933	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880934	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880935	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880936	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880937	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880938	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880939	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880940	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17880941	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	195.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	195.0
Inactive	17880942	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880943	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880944	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880945	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880946	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17880947	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	1269.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	1269.0
Inactive	17880948	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17880949	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	425.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	425.0
Inactive	17880950	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880951	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880952	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880953	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880954	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880955	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880956	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880957	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880958	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880959	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880960	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880961	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880962	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880963	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880964	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880965	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880966	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880967	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880968	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880969	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880970	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880971	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880972	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880973	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880974	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880975	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880976	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880977	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880978	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880979	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880980	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880981	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880982	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17880983	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	524.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	524.0
Inactive	17880984	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880985	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880986	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880987	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880988	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17880989	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1159.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	1159.0
Inactive	17880990	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880991	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880992	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880993	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880994	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880995	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880996	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880997	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880998	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17880999	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881000	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881001	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881002	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881003	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881004	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881005	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881006	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881007	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881008	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881009	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881010	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881011	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881012	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881013	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881014	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881015	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881016	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881017	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881018	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881019	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881020	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881021	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881022	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881023	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881024	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881025	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881026	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881027	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881028	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881029	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881030	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881031	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881032	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881033	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881034	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881035	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881036	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881037	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881038	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881039	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881040	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881041	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881042	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881043	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881044	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881045	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881046	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881047	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881048	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881049	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881050	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881051	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881052	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881053	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881054	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881055	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17881056	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	1207.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	1207.0
Inactive	17881057	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881058	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881059	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881060	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881061	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881062	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881063	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881064	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881065	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881066	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881067	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17881068	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	660.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	660.0
Inactive	17881069	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881070	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881071	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17881072	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	1.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	1.0
Inactive	17881073	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881074	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881075	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881076	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881077	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881078	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881079	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881080	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881081	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17881082	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	=	Kd	nM	549.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	549.0
Inactive	17881083	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881084	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881085	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17881086	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	4.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	4.0
Inactive	17881087	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881088	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881089	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881090	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881091	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881092	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881093	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881094	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881095	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881096	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881097	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881098	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881099	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881100	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881101	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Active	17881102	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	15258.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	15258.0
Inactive	17881103	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881104	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881105	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881106	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881107	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17881108	CHEMBL3991614	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5310	Homo sapiens	Kd apparent	nM	30000.0
	17964869	CHEMBL3994953	Inhibition of human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	90.0	CHEMBL5310	Homo sapiens	Activity	%	90.0
	17982211	CHEMBL3998848	Inhibition of human ALK4 using casein as substrate in presence of 10 uM ATP by radiometric kinase assay	A	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	=	IC50	nM	2761.0	CHEMBL5310	Homo sapiens	IC50	nM	2761.0
	17982212	CHEMBL3998848	Inhibition of human ALK4 using casein as substrate in presence of 10 uM ATP by radiometric kinase assay	A	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	43.29	CHEMBL5310	Homo sapiens	IC50	nM	43.29
	17982220	CHEMBL3998854	Inhibition of human ALK4 at 10 uM using casein as substrate in presence of 200 uM ATP by radiometric kinase assay relative to control	A	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL4099337	<	Inhibition	%	40.0	CHEMBL5310	Homo sapiens	INH	%	40.0
	18114494	CHEMBL4025000	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	18121174	CHEMBL4026810	Inhibition of human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as percent enzyme activity at 1 uM relative to control	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Activity	%	14.0	CHEMBL5310	Homo sapiens	Activity	%	14.0
	18203390	CHEMBL4043811	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	18253483	CHEMBL4055025	Inhibition of wild-type human ALK4 (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	82.0	CHEMBL5310	Homo sapiens	Activity	%	82.0
	18253484	CHEMBL4055025	Inhibition of wild-type human ALK4 (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	66.0	CHEMBL5310	Homo sapiens	Activity	%	66.0
	18282055	CHEMBL4120010	Inhibition of recombinant GST-tagged human ACVR1B catalytic domain (150 to 505 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	-6.8	CHEMBL5310	Homo sapiens	INH	%	-6.8
	18282374	CHEMBL4120010	Inhibition of recombinant GST-tagged human ACVR1B catalytic domain (150 to 505 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	2.9	CHEMBL5310	Homo sapiens	INH	%	2.9
	18286282	CHEMBL4121517	Inhibition of recombinant GST-tagged human ACVR1B catalytic domain (150 to 505 residues) expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-2.0	CHEMBL5310	Homo sapiens	INH	%	-2.0
	18440066	CHEMBL4156890	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	77.0	CHEMBL5310	Homo sapiens	Activity	%	77.0
	18484506	CHEMBL4185669	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	18485115	CHEMBL4185669	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	85.0	CHEMBL5310	Homo sapiens	Activity	%	85.0
	18489484	CHEMBL4187225	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	86.0	CHEMBL5310	Homo sapiens	Activity	%	86.0
	18507904	CHEMBL4190858	Inhibition of recombinant human ALK4 (150 to end residues) at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	80.0	CHEMBL5310	Homo sapiens	INH	%	80.0
	18655651	CHEMBL4230569	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	18663905	CHEMBL4232863	Inhibition of human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	92.0	CHEMBL5310	Homo sapiens	Activity	%	92.0
	18663976	CHEMBL4232960	Binding affinity to human ACVR1B (S187 to I505 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL5310	Homo sapiens	Kd	uM	5.0
	18674988	CHEMBL4235475	Binding affinity to human ALK4 by KdELECT assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4247751	=	Kd	nM	690.0	CHEMBL5310	Homo sapiens	Kd	nM	690.0
	18674989	CHEMBL4235475	Binding affinity to human ALK4 by KdELECT assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382	=	Kd	nM	11000.0	CHEMBL5310	Homo sapiens	Kd	nM	11000.0
Active	18674997	CHEMBL4235470	Inhibition of human ALK4 at 1 uM by scanEDGE assay	B	Cc1nc2ccc(-c3ccnc4ccccc34)c(C)c2c(=O)[nH]1		CHEMBL4247751		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	18697605	CHEMBL4254278	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	85.0	CHEMBL5310	Homo sapiens	Activity	%	85.0
	18751074	CHEMBL4263731	Inhibition of ALK4 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	29.0	CHEMBL5310	Homo sapiens	INH	%	29.0
	18751367	CHEMBL4263984	Inhibition of ALK4 (unknown origin) using Ulight topo IIa (Thr 1342) peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by TR-FRET analysis	B	CC(c1ccc(-c2cnc3c(-c4ccc(S(N)(=O)=O)c5ccccc45)cnn3c2)cc1)N1CCCC1		CHEMBL4283638	=	IC50	nM	18330.0	CHEMBL5310	Homo sapiens	IC50	nM	18330.0
	18752056	CHEMBL4264158	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	92.0	CHEMBL5310	Homo sapiens	Activity	%	92.0
	18761502	CHEMBL4266521	Inhibition of recombinant human N-terminal GST-tagged ALK4 (150 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	11.0	CHEMBL5310	Homo sapiens	INH	%	11.0
	18761740	CHEMBL4266521	Inhibition of recombinant human N-terminal GST-tagged ALK4 (150 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	-5.0	CHEMBL5310	Homo sapiens	INH	%	-5.0
	18761903	CHEMBL4266521	Inhibition of recombinant human N-terminal GST-tagged ALK4 (150 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	2.0	CHEMBL5310	Homo sapiens	INH	%	2.0
	18782441	CHEMBL4270435	Inhibition of ALK4 (unknown origin)	B	CC(=O)Nc1cc(-c2[nH]c3cccnc3c2-c2cccc(C(F)F)n2)ccn1		CHEMBL4284170	<	IC50	nM	100.0	CHEMBL5310	Homo sapiens	IC50	uM	0.1
	18782442	CHEMBL4270435	Inhibition of ALK4 (unknown origin)	B	[2H]C([2H])([2H])Oc1ccc(-c2c(-c3ccnc(NC(C)=O)c3)[nH]c3cccnc23)nc1		CHEMBL4280731	<	IC50	nM	100.0	CHEMBL5310	Homo sapiens	IC50	uM	0.1
Not Active	18847348	CHEMBL4304872	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	18857791	CHEMBL4307675	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	88.0	CHEMBL5310	Homo sapiens	Activity	%	88.0
	18892556	CHEMBL4314717	Inhibition of recombinant human ALK4 (150 to end residues) assessed as residual activity at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	93.0	CHEMBL5310	Homo sapiens	Activity	%	93.0
	18937705	CHEMBL4327582	Inhibition of human ALK4 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.37	CHEMBL5310	Homo sapiens	Activity	%	99.37
	18937706	CHEMBL4327582	Inhibition of human ALK4 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.84	CHEMBL5310	Homo sapiens	Activity	%	98.84
	18938423	CHEMBL4327943	Inhibition of human ALK4 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	<	Activity	%	65.0	CHEMBL5310	Homo sapiens	Activity	%	65.0
Not Determined	18938791	CHEMBL4328307	Inhibition of human ALK4 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL5310	Homo sapiens	IC50		
	18938792	CHEMBL4328307	Inhibition of human ALK4 using casein as substrate by [gamma-33P]-ATP assay	B	c1ccc2c(-c3cnn4cc(-c5ccc(N6CCNCC6)cc5)cnc34)ccnc2c1		CHEMBL513147	=	IC50	nM	297.0	CHEMBL5310	Homo sapiens	IC50	10'-7M	2.97
	18958694	CHEMBL4333269	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	82.0	CHEMBL5310	Homo sapiens	Activity	%	82.0
	18964058	CHEMBL4334963	Inhibition of human ALK4 (150 to end residues) assessed as residual activity at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	109.0	CHEMBL5310	Homo sapiens	Activity	%	109.0
	18964059	CHEMBL4334963	Inhibition of human ALK4 (150 to end residues) assessed as residual activity at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	105.0	CHEMBL5310	Homo sapiens	Activity	%	105.0
	18971780	CHEMBL4336790	Inhibition of human ALK4 (150 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	19021450	CHEMBL4347670	Inhibition of recombinant human ALK4 at 20 nM using Ulight-DNA topoisomerase 2alpha as substrate measured after 30 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	6.0	CHEMBL5310	Homo sapiens	INH	%	6.0
	19021451	CHEMBL4347671	Inhibition of recombinant human ALK4 at 200 nM using Ulight-DNA topoisomerase 2alpha as substrate measured after 30 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	27.0	CHEMBL5310	Homo sapiens	INH	%	27.0
Not Active	19039902	CHEMBL4351741	Inhibition of recombinant human ALK4 (150 to end residues) at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
Active	19041008	CHEMBL4352269	Inhibition of human ALK4 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	19059446	CHEMBL4357747	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	93.0	CHEMBL5310	Homo sapiens	Activity	%	93.0
	19090019	CHEMBL4365593	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	97.0	CHEMBL5310	Homo sapiens	Activity	%	97.0
	19091811	CHEMBL4366285	Inhibition of human ALK4 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-0.05	CHEMBL5310	Homo sapiens	INH	%	-0.05
	19144611	CHEMBL4377627	Inhibition of recombinant human ALK4 (150 to end residues) at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	3.0	CHEMBL5310	Homo sapiens	INH	%	3.0
	19147741	CHEMBL4379137	Inhibition of human recombinant ALK4 (150 to end residues) using casein as substrate incubated for 40 mins in presence of [gamma-33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5310	Homo sapiens	IC50	uM	10.0
	19159274	CHEMBL4382378	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	16.0	CHEMBL5310	Homo sapiens	Activity	%	16.0
	19180954	CHEMBL4387164	Inhibition of recombinant human GST-tagged ACVR1B catalytic domain (150 to 505 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	-2.0	CHEMBL5310	Homo sapiens	INH	%	-2.0
	19181180	CHEMBL4387164	Inhibition of recombinant human GST-tagged ACVR1B catalytic domain (150 to 505 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	-4.0	CHEMBL5310	Homo sapiens	INH	%	-4.0
	19191251	CHEMBL4389574	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	83.0	CHEMBL5310	Homo sapiens	INH	%	83.0
	19191733	CHEMBL4389097	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL5310	Homo sapiens	INH	%	100.0
	19200022	CHEMBL4391200	Binding affinity to wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	67.0	CHEMBL5310	Homo sapiens	Activity	%	67.0
	19266308	CHEMBL4405258	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5310	Homo sapiens	INH	%	50.0
	19275927	CHEMBL4407930	Inhibition of recombinant human ALK4 (150 to end residues) at 1 uM using as casein substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	46.0	CHEMBL5310	Homo sapiens	INH	%	46.0
	19476546	CHEMBL4479694	Inhibition of recombinant human GST-tagged ALK4 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	200.0	CHEMBL5310	Homo sapiens	IC50	nM	200.0
	19476646	CHEMBL4479694	Inhibition of recombinant human GST-tagged ALK4 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	170.0	CHEMBL5310	Homo sapiens	IC50	nM	170.0
	19476746	CHEMBL4479694	Inhibition of recombinant human GST-tagged ALK4 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	730.0	CHEMBL5310	Homo sapiens	IC50	nM	730.0
	19476846	CHEMBL4479694	Inhibition of recombinant human GST-tagged ALK4 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	>	IC50	nM	100000.0	CHEMBL5310	Homo sapiens	IC50	nM	100000.0
	20600462	CHEMBL4603287	Inhibition of recombinant GST-tagged human ALK4 (150 to 505 residues) expressed in baculovirus expression system using Ser/Thr-16 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5310	Homo sapiens	IC50	uM	100.0
	20690529	CHEMBL4625384	Inhibition of ALK4 (unknown origin) assessed as enzyme remaining activity at 10 uM relative to control	B	NS(=O)(=O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3C3CCOCC3)ccn2)ccc1F		CHEMBL4646566	=	Activity	%	2.0	CHEMBL5310	Homo sapiens	Activity	%	2.0
	20694076	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC		CHEMBL3341787	=	IC50	nM	462.0	CHEMBL5310	Homo sapiens	IC50	nM	462.0
	20694077	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	1336.0	CHEMBL5310	Homo sapiens	IC50	nM	1336.0
	20694078	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2F)cc(OC)c1OC		CHEMBL4633121	=	IC50	nM	630.0	CHEMBL5310	Homo sapiens	IC50	nM	630.0
	20694079	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2Cl)cc(OC)c1OC		CHEMBL4642165	=	IC50	nM	962.0	CHEMBL5310	Homo sapiens	IC50	nM	962.0
	20694080	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C#N)cc(OC)c1OC		CHEMBL4638273	=	IC50	nM	257.0	CHEMBL5310	Homo sapiens	IC50	nM	257.0
	20694081	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	=	IC50	nM	1503.0	CHEMBL5310	Homo sapiens	IC50	nM	1503.0
	20694082	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4638544	=	IC50	nM	1131.0	CHEMBL5310	Homo sapiens	IC50	nM	1131.0
	20694083	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241	>	IC50	nM	2000.0	CHEMBL5310	Homo sapiens	IC50	nM	2000.0
	20694084	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(C4=CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4641530	>	IC50	nM	2000.0	CHEMBL5310	Homo sapiens	IC50	nM	2000.0
	20694085	CHEMBL4626172	Inhibition of human ALK4 using casein as substrate in presence of [gamma-33P]-ATP by radiometric hotspot assay	A	COc1cc(-c2cncc(-c3ccc(OC4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4648102	=	IC50	nM	1363.0	CHEMBL5310	Homo sapiens	IC50	nM	1363.0
	22391934	CHEMBL4667085	Inhibition of recombinant human GST-tagged ACVR1B (150 to 505 residues) expressed in baculovirus expression system using Ser/Thr 16 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-1.5	CHEMBL5310	Homo sapiens	INH	%	-1.5
	22423837	CHEMBL4674494	Inhibition of human ALK4 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	101.01	CHEMBL5310	Homo sapiens	Activity	%	101.01
	22423838	CHEMBL4674494	Inhibition of human ALK4 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	98.77	CHEMBL5310	Homo sapiens	Activity	%	98.77
	22820422	CHEMBL4716213	Inhibition of N-terminal GST-tagged human recombinant ALK4 (150 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	98.0	CHEMBL5310	Homo sapiens	Activity	%	98.0
	22820423	CHEMBL4716213	Inhibition of N-terminal GST-tagged human recombinant ALK4 (150 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	5.0	CHEMBL5310	Homo sapiens	Activity	%	5.0
	22844318	CHEMBL4721181	Inhibition of human ALK4 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	93.01	CHEMBL5310	Homo sapiens	Activity	%	93.01
	22844618	CHEMBL4721293	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	84.46	CHEMBL5310	Homo sapiens	Activity	%	84.46
	22884270	CHEMBL4727756	Inhibition of human ALK4 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2ccccc2n1		CHEMBL4740381	=	IC50	nM	464.0	CHEMBL5310	Homo sapiens	IC50	nM	464.0
	22884271	CHEMBL4727756	Inhibition of human ALK4 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)ccc2n1		CHEMBL4788859	=	IC50	nM	568.7	CHEMBL5310	Homo sapiens	IC50	nM	568.7
	22884272	CHEMBL4727756	Inhibition of human ALK4 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(N5CCNCC5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4786529	=	IC50	nM	596.1	CHEMBL5310	Homo sapiens	IC50	nM	596.1
	22884273	CHEMBL4727756	Inhibition of human ALK4 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2ccccc2n1		CHEMBL4742906	=	IC50	nM	192.0	CHEMBL5310	Homo sapiens	IC50	nM	192.0
	22884274	CHEMBL4727756	Inhibition of human ALK4 using casein as substrate by [gamma-33P]-ATP assay	B	Cc1cc(-c2cnc3cc(-c4ccc(C5CNCCN5)cc4)ccn23)c2cc(F)cc(F)c2n1		CHEMBL4778971	=	IC50	nM	390.0	CHEMBL5310	Homo sapiens	IC50	nM	390.0
	22886504	CHEMBL4728241	Binding affinity to ACVR1B (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	6.0	CHEMBL5310	Homo sapiens	deltaTm	degrees C	6.0
Not Active	22889480	CHEMBL4728999	Inhibition of wild-type human ACVR1B (S187 to I505 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL5310	Homo sapiens	INH		
	22952749	CHEMBL4766686	Inhibition of human ALK4 (150 to end residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	98.0	CHEMBL5310	Homo sapiens	Activity	%	98.0
	23122231	CHEMBL4804703	Inhibition of ALK4 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	84000.0	CHEMBL5310	Homo sapiens	IC50	uM	84.0
	23122232	CHEMBL4804703	Inhibition of ALK4 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	76200.0	CHEMBL5310	Homo sapiens	IC50	uM	76.2
	23122233	CHEMBL4804703	Inhibition of ALK4 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	91000.0	CHEMBL5310	Homo sapiens	IC50	uM	91.0
	23122234	CHEMBL4804704	Inhibition of ALK4 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	75.0	CHEMBL5310	Homo sapiens	INH	%	75.0
	23122235	CHEMBL4804704	Inhibition of ALK4 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	75.0	CHEMBL5310	Homo sapiens	INH	%	75.0
	23122236	CHEMBL4804704	Inhibition of ALK4 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	>	Inhibition	%	90.0	CHEMBL5310	Homo sapiens	INH	%	90.0
	23122432	CHEMBL4804783	Inhibition of human ACVR1B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	92.0	CHEMBL5310	Homo sapiens	Activity	%	92.0
	23123127	CHEMBL4805371	Inhibition of human ACVR1B assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	94.0	CHEMBL5310	Homo sapiens	Activity	%	94.0
	23123758	CHEMBL4806002	Inhibition of DNA-tagged human ACVR1B assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	23124344	CHEMBL4806388	Inhibition of human ACVR1B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5310	Homo sapiens	Activity	%	100.0
	23124345	CHEMBL4806388	Inhibition of human ACVR1B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL5310	Homo sapiens	Activity	%	99.0
	23127492	CHEMBL4807634	Inhibition of ACVR1B (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	1.0	CHEMBL5310	Homo sapiens	Activity	%	1.0
	23127493	CHEMBL4807634	Inhibition of ACVR1B (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	41.0	CHEMBL5310	Homo sapiens	Activity	%	41.0
	23127494	CHEMBL4807634	Inhibition of ACVR1B (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	10.0	CHEMBL5310	Homo sapiens	Activity	%	10.0
	23127789	CHEMBL4807738	Inhibition of ACVR1B (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL5310	Homo sapiens	Activity	%	25.0
	23127790	CHEMBL4807738	Inhibition of ACVR1B (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	25.0	CHEMBL5310	Homo sapiens	Activity	%	25.0
	23127791	CHEMBL4807738	Inhibition of ACVR1B (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL5310	Homo sapiens	Activity	%	25.0
	23183204	CHEMBL4817029	Inhibition of human ALK4 using ATP as substrate incubated for 60 mins by ADP-glo based luminescence assay	B	O=C(O)c1ccc(-c2nc(-c3ccc4c(c3)OCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL6250	=	IC50	nM	158.0	CHEMBL5310	Homo sapiens	IC50	nM	158.0
	23183205	CHEMBL4817029	Inhibition of human ALK4 using ATP as substrate incubated for 60 mins by ADP-glo based luminescence assay	B	O=S1(=O)CC2(OCCO2)c2cc3nccc(Nc4ccc5scnc5c4)c3cc21		CHEMBL4861646	=	IC50	nM	3737.0	CHEMBL5310	Homo sapiens	IC50	nM	3737.0
Not Active	23317267	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	77.0	CHEMBL5310	Homo sapiens	% Control	%	77.0
Not Active	23317735	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	82.0	CHEMBL5310	Homo sapiens	% Control	%	82.0
Not Active	23318409	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	87.0	CHEMBL5310	Homo sapiens	% Control	%	87.0
Not Active	23318885	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23319525	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	96.4	CHEMBL5310	Homo sapiens	% Control	%	96.4
Not Active	23319997	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	96.4	CHEMBL5310	Homo sapiens	% Control	%	96.4
Not Active	23320675	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	85.0	CHEMBL5310	Homo sapiens	% Control	%	85.0
Not Active	23321143	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23321773	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	99.0	CHEMBL5310	Homo sapiens	% Control	%	99.0
Not Active	23322241	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	90.0	CHEMBL5310	Homo sapiens	% Control	%	90.0
Not Active	23322930	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	67.0	CHEMBL5310	Homo sapiens	% Control	%	67.0
Not Active	23323398	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	82.0	CHEMBL5310	Homo sapiens	% Control	%	82.0
Not Active	23323949	CHEMBL4880568	ALK4 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	4.0	CHEMBL5310	Homo sapiens	% inhibition	%	4.0
Not Active	23324252	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23324887	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	74.0	CHEMBL5310	Homo sapiens	% Control	%	74.0
Not Active	23325355	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23326002	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	98.0	CHEMBL5310	Homo sapiens	% Control	%	98.0
Not Active	23326470	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	89.0	CHEMBL5310	Homo sapiens	% Control	%	89.0
Not Active	23327170	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	94.0	CHEMBL5310	Homo sapiens	% Control	%	94.0
Not Active	23327638	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	87.0	CHEMBL5310	Homo sapiens	% Control	%	87.0
Not Active	23328225	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	80.0	CHEMBL5310	Homo sapiens	% Control	%	80.0
Not Active	23328693	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	80.0	CHEMBL5310	Homo sapiens	% Control	%	80.0
Not Active	23329243	CHEMBL4880950	ALK4(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	98.0	CHEMBL5310	Homo sapiens	% residual kinase activity	%	98.0
Not Active	23329639	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	79.0	CHEMBL5310	Homo sapiens	% Control	%	79.0
Not Active	23330107	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	86.0	CHEMBL5310	Homo sapiens	% Control	%	86.0
Not Active	23330863	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23331331	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23331918	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23332386	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23333102	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23333741	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	91.0	CHEMBL5310	Homo sapiens	% Control	%	91.0
Not Active	23334209	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23335188	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	87.0	CHEMBL5310	Homo sapiens	% Control	%	87.0
Not Active	23335656	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	98.0	CHEMBL5310	Homo sapiens	% Control	%	98.0
Not Active	23336283	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23336751	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	92.0	CHEMBL5310	Homo sapiens	% Control	%	92.0
Not Active	23337507	CHEMBL4881878	ACVR1B Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	104.0	CHEMBL5310	Homo sapiens	% Ctrl	%	104.0
Not Active	23337832	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	89.0	CHEMBL5310	Homo sapiens	% Control	%	89.0
Not Active	23338300	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	84.0	CHEMBL5310	Homo sapiens	% Control	%	84.0
Not Active	23338912	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23339380	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23340017	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23340485	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23341142	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	93.0	CHEMBL5310	Homo sapiens	% Control	%	93.0
Not Active	23341610	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23342226	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	81.0	CHEMBL5310	Homo sapiens	% Control	%	81.0
Not Active	23342694	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23343239	CHEMBL4882424	ACVR1B Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	100.0	CHEMBL5310	Homo sapiens	% Ctrl	%	100.0
Not Active	23343324	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	86.0	CHEMBL5310	Homo sapiens	% Control	%	86.0
Not Active	23343792	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	83.0	CHEMBL5310	Homo sapiens	% Control	%	83.0
Not Active	23344430	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	79.0	CHEMBL5310	Homo sapiens	% Control	%	79.0
Not Active	23345003	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23345471	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23346048	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	92.7	CHEMBL5310	Homo sapiens	% Control	%	92.7
Not Active	23346517	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23347127	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23347608	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	76.1	CHEMBL5310	Homo sapiens	% Control	%	76.1
Not Active	23348187	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	94.0	CHEMBL5310	Homo sapiens	% Control	%	94.0
Not Active	23348655	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	92.0	CHEMBL5310	Homo sapiens	% Control	%	92.0
Not Active	23349242	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	87.0	CHEMBL5310	Homo sapiens	% Control	%	87.0
Not Active	23349860	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23350328	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	83.0	CHEMBL5310	Homo sapiens	% Control	%	83.0
Not Active	23350933	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	96.0	CHEMBL5310	Homo sapiens	% Control	%	96.0
Not Active	23351401	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	99.0	CHEMBL5310	Homo sapiens	% Control	%	99.0
Not Active	23351956	CHEMBL4882649	ACVR1B (ALK4) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-0.7235	CHEMBL5310	Homo sapiens	% Inhibition	%	-0.7235
Not Active	23352425	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	90.0	CHEMBL5310	Homo sapiens	% Control	%	90.0
Not Active	23352893	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	78.0	CHEMBL5310	Homo sapiens	% Control	%	78.0
Not Active	23353775	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23354243	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23354975	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	86.0	CHEMBL5310	Homo sapiens	% Control	%	86.0
Not Active	23355443	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	89.0	CHEMBL5310	Homo sapiens	% Control	%	89.0
Not Active	23356079	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	99.0	CHEMBL5310	Homo sapiens	% Control	%	99.0
Not Active	23356547	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	98.0	CHEMBL5310	Homo sapiens	% Control	%	98.0
Not Active	23357156	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23357803	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	88.0	CHEMBL5310	Homo sapiens	% Control	%	88.0
Not Active	23358271	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	79.0	CHEMBL5310	Homo sapiens	% Control	%	79.0
Not Active	23358857	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	89.4	CHEMBL5310	Homo sapiens	% Control	%	89.4
Not Active	23359455	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23359923	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23360508	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	96.0	CHEMBL5310	Homo sapiens	% Control	%	96.0
Not Active	23360976	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	96.0	CHEMBL5310	Homo sapiens	% Control	%	96.0
Not Active	23361549	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23362085	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	93.0	CHEMBL5310	Homo sapiens	% Control	%	93.0
Not Active	23362553	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	75.0	CHEMBL5310	Homo sapiens	% Control	%	75.0
Active	23363405	CHEMBL4883281	Lathascreen (Takeda) (ACVR1B)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126		IC50	nM	1000.0	CHEMBL5310	Homo sapiens	pIC50		6.0
Active	23363408	CHEMBL4883284	Reporter gene assay (ACVR1B)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126		IC50	nM	526.0	CHEMBL5310	Homo sapiens	IC50	nM	526.0
Active	23363410	CHEMBL4883286	Radioactive kinase assay (ACVR1B)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126		IC50	nM	125.89	CHEMBL5310	Homo sapiens	pIC50		6.9
Not Active	23363424	CHEMBL4883293	NanoBRET (SGC Frankfurt) (ACVR1B)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2ccccc21	Non standard unit for type	CHEMBL4543737	>	IC50	M	10.0	CHEMBL5310	Homo sapiens	IC50	M	10.0
Not Active	23364195	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	67.0	CHEMBL5310	Homo sapiens	% Control	%	67.0
Not Active	23364663	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	59.0	CHEMBL5310	Homo sapiens	% Control	%	59.0
Not Active	23365402	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23365945	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	90.0	CHEMBL5310	Homo sapiens	% Control	%	90.0
Not Active	23366535	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23367003	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23367465	CHEMBL4883818	ACV-R1B ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	77.0	CHEMBL5310	Homo sapiens	% Residual activity with Skepinone-L	%	77.0
Not Active	23367881	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23368349	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL5310	Homo sapiens	% Control	%	94.0
Not Active	23368948	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	94.0	CHEMBL5310	Homo sapiens	% Control	%	94.0
Not Active	23369416	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	91.0	CHEMBL5310	Homo sapiens	% Control	%	91.0
Not Active	23369968	CHEMBL4884215	ALK4(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	90.0	CHEMBL5310	Homo sapiens	% residual kinase activity	%	90.0
Not Active	23370384	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23370852	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	80.0	CHEMBL5310	Homo sapiens	% Control	%	80.0
Not Active	23371661	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	96.0	CHEMBL5310	Homo sapiens	% Control	%	96.0
Not Active	23372129	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	94.0	CHEMBL5310	Homo sapiens	% Control	%	94.0
	23373705	CHEMBL4885482	ALK4(AC1BLGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5310	Homo sapiens	pIC50		6.0
Not Active	23374910	CHEMBL4885904	ACVR1B Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	-1.0	CHEMBL5310	Homo sapiens	% Inhibition	%	-1.0
Not Active	23375556	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	93.0	CHEMBL5310	Homo sapiens	% Control	%	93.0
Not Active	23376024	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23376602	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23377071	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	99.0	CHEMBL5310	Homo sapiens	% Control	%	99.0
Not Active	23377929	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	86.0	CHEMBL5310	Homo sapiens	% Control	%	86.0
Not Active	23378397	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23379564	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	94.0	CHEMBL5310	Homo sapiens	% Control	%	94.0
Not Active	23380032	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	69.0	CHEMBL5310	Homo sapiens	% Control	%	69.0
Not Active	23380726	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	78.0	CHEMBL5310	Homo sapiens	% Control	%	78.0
Not Active	23381374	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	99.0	CHEMBL5310	Homo sapiens	% Control	%	99.0
Not Active	23381842	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23382466	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	69.0	CHEMBL5310	Homo sapiens	% Control	%	69.0
Slightly Active	23382934	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	26.0	CHEMBL5310	Homo sapiens	% Control	%	26.0
Not Active	23383689	CHEMBL4887344	ACVR1B Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	96.0	CHEMBL5310	Homo sapiens	% Ctrl	%	96.0
Not Active	23383690	CHEMBL4887344	ACVR1B Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	105.0	CHEMBL5310	Homo sapiens	% Ctrl	%	105.0
Not Active	23384175	CHEMBL4887770	Alk4(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-3.68	CHEMBL5310	Homo sapiens	% inhibition	%	-3.68
Not Active	23384626	CHEMBL4888152	ACVR1B (ALK4) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1	Outside typical range	CHEMBL4795065		Inhibition	%	-13.0	CHEMBL5310	Homo sapiens	% Inhibition	%	-13.0
Not Active	23384849	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	72.0	CHEMBL5310	Homo sapiens	% Control	%	72.0
Not Active	23385316	CHEMBL4879573	KinomeScan assay: inhibition of ACVR1B	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5310	Homo sapiens	% Control	%	100.0
Not Active	23385860	CHEMBL4888333	Alk4 Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	-5.0	CHEMBL5310	Homo sapiens	% inhibition	%	-5.0
